Trial intelligence / Profile preview

Fluticasone Furoate in Persistent Asthma

NCT01436071Phase 3Completed

Sponsor
GSK
Start
Sep 2011
Primary completion
Jun 2012
Modality
Orthosteric Ligands
Countries
4
01

Overview

A Phase 3 trial of fluticasone in asthma, sponsored by GSK. Started Sep 2011; status: completed.

02

Drugs

fluticasone
03

Conditions

asthma

Beyond the preview

Go deeper on NCT01436071.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01436071.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call